Brazilian contrast agent death toll rises
This article was originally published in Clinica
Executive Summary
The death toll and cases of "severe side effects" linked to the Celobar contrast agent in Brazil has risen across four states, reported yesterday (June 2 2003) the national healthcare surveillance agency, Anvisa.